-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Clearside Biomedical, Maintains $5 Price Target

Benzinga·05/16/2025 15:51:26
Listen to the news
JMP Securities analyst Jonathan Wolleben reiterates Clearside Biomedical (NASDAQ:CLSD) with a Market Outperform and maintains $5 price target.